Lv1
70 积分 2025-11-22 加入
CAR-T cell therapy: Where are we now, and where are we heading?
2小时前
已完结
CAR-X cell engineering
3天前
已完结
Potential of chimeric antigen receptor (CAR) T cell immunotherapy in systemic lupus erythematosus (SLE)
25天前
已完结
In-vivo B-cell maturation antigen CAR T-cell therapy for relapsed or refractory multiple myeloma
1个月前
已完结
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
1个月前
已完结
B cell depletion in autoimmune disease: in vivo CAR-T or T cell engagers?
1个月前
已完结
CD19 CAR T-Cell Therapy in Multidrug-Resistant Ulcerative Colitis
2个月前
已完结
Fever of Unknown Origin
2个月前
已完结
Anti-CD19 CAR T cells for pediatric patients with treatment-refractory autoimmune diseases
2个月前
已完结
Selective targeting of mutated calreticulin by the monoclonal antibody INCA033989 inhibits oncogenic function of MPN
2个月前
已完结
皖公网安备34019202002308
